Adam Hansard is CCO at Applied Therapeutics, Inc. (APLT). They have made 5 open-market trades across 1 company since 2021, most recently 2024-03-14.
CIK 0001805556
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| APLT | 732,919 | $75K |
Shares reported on the most recent Form 4, priced at the 2024-03-18 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| APLT | SELL | 2024-03-14 | 2024-03-18 | $5.39 | $527K | +19.3% | -15.3% | -15.3% |
| APLT | SELL | 2023-11-30 | 2023-12-01 | $1.97 | $2K | +24.0% | +50.4% | +194.2% |
| APLT | SELL | 2023-09-27 | 2023-09-29 | $2.70 | $26K | -3.7% | +3.3% | +28.1% |
| APLT | SELL | 2023-01-11 | 2023-01-13 | $0.91 | $4K | +16.3% | +3.1% | -14.6% |
| APLT | SELL | 2021-05-26 | 2021-05-28 | $18.35 | $106K | +18.2% | +13.5% | -7.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.